The following speakers have received an honorarium from Novo Nordisk for their input to and facilitation of this educational material:
- Prof. Aleksander Krag, University of Southern Denmark, Odense University Hospital
- Prof. Juan Mendive, Catalan Institute of Health, University of Barcelona
1. Kounossi ZM, et al. Hepatology. 2023;77:1335–1347
2. Abe RM, et al. Cureus. 2021;13:e16855
3. Blanco-Grau A, et al. Diagnostics. 2021;11:2236
- To raise awareness of MASLD/MASH as a manifestation of metabolic disease
- To improve understanding of risk factors and comorbidities for MASLD/MASH and the progressive nature of these diseases
- To highlight the role of primary care in the timely diagnosis of MASLD/MASH and the importance of appropriate specialist referral
- To discuss optimal multidisciplinary collaboration between primary care and hepatology for the management of people with MASLD/MASH
